Cargando…
Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infection...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527505/ https://www.ncbi.nlm.nih.gov/pubmed/18710491 http://dx.doi.org/10.1186/1756-0500-1-38 |
_version_ | 1782158810042859520 |
---|---|
author | Zhao, Haitian Dreses-Werringloer, Ute Davies, Peter Marambaud, Philippe |
author_facet | Zhao, Haitian Dreses-Werringloer, Ute Davies, Peter Marambaud, Philippe |
author_sort | Zhao, Haitian |
collection | PubMed |
description | BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis. FINDINGS: Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Aβ. As a result, we observed no accumulation of Aβ in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-β precursor protein (APP). Importantly, eradication of the mycoplasma contaminant – identified as M. hyorhinis – by treatments with a quinolone-based antibiotic, restored extracellular Aβ accumulation in the APP-transfected cells. CONCLUSION: These data show that mycoplasmas degrade Aβ and thus may represent a significant source of variability when comparing extracellular Aβ levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Aβ level measurements in cultured cells. |
format | Text |
id | pubmed-2527505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25275052008-09-01 Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants Zhao, Haitian Dreses-Werringloer, Ute Davies, Peter Marambaud, Philippe BMC Res Notes Short Report BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis. FINDINGS: Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Aβ. As a result, we observed no accumulation of Aβ in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-β precursor protein (APP). Importantly, eradication of the mycoplasma contaminant – identified as M. hyorhinis – by treatments with a quinolone-based antibiotic, restored extracellular Aβ accumulation in the APP-transfected cells. CONCLUSION: These data show that mycoplasmas degrade Aβ and thus may represent a significant source of variability when comparing extracellular Aβ levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Aβ level measurements in cultured cells. BioMed Central 2008-06-30 /pmc/articles/PMC2527505/ /pubmed/18710491 http://dx.doi.org/10.1186/1756-0500-1-38 Text en Copyright © 2008 Zhao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Zhao, Haitian Dreses-Werringloer, Ute Davies, Peter Marambaud, Philippe Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title | Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title_full | Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title_fullStr | Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title_full_unstemmed | Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title_short | Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
title_sort | amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527505/ https://www.ncbi.nlm.nih.gov/pubmed/18710491 http://dx.doi.org/10.1186/1756-0500-1-38 |
work_keys_str_mv | AT zhaohaitian amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants AT dreseswerringloerute amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants AT daviespeter amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants AT marambaudphilippe amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants |